The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maksumova, L.
Right arrow Articles by Pallen, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maksumova, L.
Right arrow Articles by Pallen, C. J.
The Journal of Immunology, 2005, 175: 7947-7956.
Copyright © 2005 by The American Association of Immunologists

Protein Tyrosine Phosphatase {alpha} Regulates Fyn Activity and Cbp/PAG Phosphorylation in Thymocyte Lipid Rafts1

Lola Maksumova*, Hoa T. Le{dagger}, Farkhad Muratkhodjaev*, Dominique Davidson{ddagger}, André Veillette{ddagger} and Catherine J. Pallen2,*,{dagger}

* Department of Pediatrics and {dagger} Departments of Pathology and Laboratory Medicine, British Columbia Research Institute for Children’s and Women’s Health, University of British Columbia, Vancouver, Canada; and {ddagger} Clinical Research Institute of Montreal, Montreal, Canada


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
A role for the receptor protein tyrosine phosphatase {alpha} (PTP{alpha}) in immune cell function and regulation of Src family kinases was investigated using thymocytes from PTP{alpha}-deficient mice. PTP{alpha}-null thymocytes develop normally, but unstimulated PTP{alpha}–/– cells exhibit increased tyrosine phosphorylation of specific proteins, increased Fyn activity, and hyperphosphorylation of Cbp/PAG that promotes its association with C-terminal Src kinase. Elevated Fyn activity in the absence of PTP{alpha} is due to enhanced phosphorylation of Fyn tyrosines 528 and 417. Some PTP{alpha} is localized in lipid rafts of thymocytes, and raft-associated Fyn is specifically activated in PTP{alpha}–/– cells. PTP{alpha} is not a Cbp/PAG phosphatase, because it is not required for Cbp/PAG dephosphorylation in unstimulated or anti-CD3-stimulated thymocytes. Together, our results indicate that PTP{alpha}, likely located in lipid rafts, regulates the activity of raft Fyn. In the absence of PTP{alpha} this population of Fyn is activated and phosphorylates Cbp/PAG to enhance association with C-terminal Src kinase. Although TCR-mediated tyrosine phosphorylation was apparently unaffected by the absence of PTP{alpha}, the long-term proliferative response of PTP{alpha}–/– thymocytes was reduced. These findings indicate that PTP{alpha} is a component of the complex Src family tyrosine kinase regulatory network in thymocytes and is required to suppress Fyn activity in unstimulated cells in a manner that is not compensated for by the major T cell PTP and SFK regulator, CD45.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Protein tyrosine phosphatase {alpha} (PTP{alpha})3 is a widely expressed transmembrane enzyme that functions to regulate Src family tyrosine kinases (SFKs) (reviewed in Ref.1). Overexpression of PTP{alpha} in fibroblasts, embryonal carcinoma cells, PC12 cells, and A431 cells respectively induces transformation (2), promotes neuronal differentiation (3) and outgrowth (4), or enhances adhesion of cells to the substratum (5) that is concomitant with Src activation. PTP{alpha} expression can also induce Fyn activation (6). Conversely, mice with targeted disruption of the PTP{alpha} gene have substantially reduced brain Src and Fyn activity (7, 8). Embryonic fibroblasts from PTP{alpha}-deficient mice have reduced activity of these SFKs and consequently impaired integrin signaling that is manifested by delayed cell spreading, migration, and haptotaxis (7, 8, 9). PTP{alpha}-mediated SFK activation is achieved through dephosphorylation of the C-terminal regulatory tyrosine residue of the SFKs (2, 3, 7, 8). The above studies have established a role for PTP{alpha} as an SFK phosphatase and positive regulator of the SFKs in multiple contexts.

PTP{alpha} has never been implicated in immune cell signaling, in which SFKs play key initial roles. In T cells, regulated tyrosine phosphorylation is key to TCR signaling and consequent cell proliferation (10). An early recognizable event upon TCR engagement is the induction of protein tyrosine phosphorylation by the SFKs Lck and Fyn. Indeed, Lck- or Fyn-deficient cell lines and mice show defects in T cell signaling and proliferation (11, 12, 13, 14, 15). Activated Lck and Fyn phosphorylate immunoreceptor-based tyrosine activation motifs in the TCR/CD3 subunits, resulting in recruitment and activation of the Syk family tyrosine kinase Zap70 (16, 17). Phosphorylation by Zap70 or other proteins such as linker for activation of T cells (LAT) and SH2 domain-containing leukocyte protein of 76 kDa (18, 19) mediates the formation of multicomponent complexes and activates several T cell-signaling pathways (20, 21).

Lck and Fyn activities are closely regulated before and upon T cell stimulation. The receptor PTP CD45 can positively regulate Lck activity by dephosphorylating an inhibitory phosphotyrosine in the C-terminal tail of Lck (Tyr505) and can also negatively regulate Lck by dephosphorylating the autophosphorylation loop tyrosine (Tyr394) (22, 23, 24, 25, 26, 27, 28, 29, 30, 31). Studies using CD45-deficient cell lines and thymocytes indicate that in an unstimulated T cell, CD45 dephosphorylates both regulatory tyrosines of Lck with an overall effect of limiting kinase activity (28, 32). It is proposed that upon T cell activation, CD45 loses its proximity to Lck, resulting in rephosphorylation of Tyr394 and activation of Lck (33). Activated Lck colocalizes with and activates Fyn (34, 35). T cell SFK phosphorylation and activities are also modulated by the tyrosine kinase C-terminal Src kinase (Csk). In unstimulated T cells, constitutive tyrosine phosphorylation of the transmembrane protein Csk-binding protein (Cbp)/PAG (phosphoprotein associated with glycosphingolipid-enriched microdomains) promotes formation of a Csk-Cbp/PAG complex mediated through Csk-Src homology 2 (SH2) domain binding to phospho-Tyr314 of Cbp/PAG (36, 37). In this way, Csk is localized at the membrane where it can phosphorylate the C-terminal tyrosine residue of SFKs to inhibit their activities (36, 37, 38), perhaps counteracting the activity of CD45 on this site and contributing to overall low SFK activity. Csk also associates through its SH3 domain with PEP (39), a PTP implicated in the negative regulation of TCR signaling through its dephosphorylation of the activation loop tyrosine in SFKs (40). A membrane-localized Csk-PEP complex could augment the negative regulation of SFKs in unstimulated T cells. T cell stimulation rapidly induces dephosphorylation of Cbp/PAG, with release and relocalization of Csk to the cytosol, thus relieving Csk-mediated SFK inhibition (36, 41). CD45 itself is required for efficient TCR-stimulated Cbp/PAG dephosphorylation (38). Thus, the phosphorylation and activities of Lck and Fyn are modulated by an interactive network of kinases and phosphatases that is still not well understood. Functional outcomes are likely to be orchestrated by dynamic, regulated localization of components of this kinase-phosphatase signaling module to the membrane and, in particular, to the lipid rafts that are proposed to serve as platforms for T cell signaling (42, 43).

The role of PTP{alpha} as an activator of Src and Fyn in nonimmune cells together with the critical roles played by activated SFKs in TCR-mediated signaling led us to investigate a potential T cell function of PTP{alpha} as a regulator of SFK activity. Altered Fyn phosphorylation and enhanced Fyn activity were detected in unstimulated thymocytes from PTP{alpha}-deficient mice, specifically involving a population of Fyn that colocalizes with PTP{alpha} in lipid rafts. Also, PTP{alpha} indirectly regulates phosphorylation of the lipid raft protein Cbp/PAG and its association with the SFK kinase inhibitor Csk. Although TCR-mediated tyrosine phosphorylation was apparently unaffected by the absence of PTP{alpha}, the long-term proliferative response of PTP{alpha}–/– thymocytes was reduced. PTP{alpha} thus plays a novel and unique role in resting thymocytes as a positive and negative Src family kinase regulator, and is required for optimal TCR-mediated thymocyte proliferation.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Mice and cell lines

The PTP{alpha}-deficient mice have been previously described (7) and were maintained as an advanced intercross line (129SvEv x Black Swiss, 50:50 mixed background). Animal care and use followed the guidelines of the Canadian Council on Animal Care and were reviewed and approved by the University of British Columbia. All experiments were conducted with 8- to 9-wk-old mice. The Jurkat cell line JE6.1 and a derivative cell line lacking CD45 expression (J45.01) were provided by Dr. P. Johnson (University of British Columbia, Vancouver, Canada).

Reagents and Abs

Abs to phosphotyrosine (PY-20), CD45, CD28, Fyn, Lck, and Csk were purchased from BD Transduction Laboratories. Other Abs to phosphotyrosine (4G10; Upstate Biotechnology), Fyn (Santa Cruz Biotechnology), and transferrin receptor (Zymed Laboratories) were also used. Fyn phosphorylation status was investigated using phosphosite-specific Abs raised to the C-terminal phosphorylation site (pTyr529) and autophosphorylation site (pTyr418) of Src (BioSource International) that can recognize homologous phosphorylation sites in Fyn. Anti-LAT Ab was purchased from Santa Cruz Biotechnology. FITC-conjugated anti-CD4 and PE-conjugated anti-CD8a Abs, FITC-conjugated anti-CD25 and -CD69 Abs, and appropriate isotype controls, were purchased from eBioscience. Anti-{beta}-actin Ab, anti-hamster IgG, n-octyl {beta}-glucopyranoside, PMA, and ionomycin were obtained from Sigma-Aldrich. PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d]pyrimidine) was purchased from Tocris Cookson, and PP3 (4-amino-7-phenylpyrazol[3,4-{alpha}]pyrimidine) was obtained from Calbiochem. Purified anti-CD3{epsilon} Ab (clone 145.2C11) was prepared in our laboratory. Rabbit anti-PTP{alpha} antiserum 2205 (44) and mouse anti-Cbp/PAG antiserum (38) have been previously described.

T cell preparation

Thymus, spleen, or mesenteric lymph nodes were compressed with a syringe plunger and passed through a 100-µm pore size nylon cell strainer (Falcon; BD Biosciences) to produce single-cell suspensions. After depletion of RBC, thymocytes, splenocytes, and lymph node lymphocytes were used for experiments. For proliferation studies, CD3+ and naive CD4+ T cells were purified from thymocyte suspensions using murine T Cell and CD4+ T Cell Enrichment kits (StemCell Technologies).

Flow cytometry

Single-cell suspensions of 1 x 106 thymocytes or splenocytes were incubated (30 min, 4°C) with saturating amounts of FITC-conjugated anti-CD4 and PE-conjugated anti-CD8a Abs and appropriate isotype controls. Cells were washed twice with PBS and resuspended in equal amounts of RPMI 1640 for analysis on a FACSCalibur flow cytometer (BD Biosciences).

T cell stimulation

For proliferation experiments, purified CD3+ and CD4+ T cells (2 x 105) or lymph node T cells (5 x 104) were cultured in 100 µl of RPMI 1640 medium supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin. Cells were stimulated in triplicate with plate-bound anti-CD3 (10 µg/ml) and/or anti-CD28 (5 µg/ml) Abs or with 1 ng/ml PMA and 200 ng/ml ionomycin for 48 h at 37°C, then pulsed with [3H]thymidine (PerkinElmer) for the final 18 h of culture and harvested onto printed glass-fiber filtermates (Wallac) using a cell harvester. [3H]Thymidine incorporation was measured using a multidetector liquid scintillation counter. The IL-2 concentration in the supernatants was assayed using an ELISA kit from eBioscience.

For stimulation before lysis, 1 x 107 thymocytes in 0.5 ml of RPMI 1640 medium were incubated for 10 min with 20 µg/ml anti-CD3{epsilon}, then cross-linked with anti-hamster IgG at 37°C for various times as indicated in the figures. The cells were pelleted by brief (20-s) centrifugation and lysed with Triton-based buffer (20 mM Tris (pH 7.4), 120 mM NaCl, 1% Triton X-100, 5 mM EDTA, 50 mM sodium fluoride, 1 mM Na3VO4, and 10 µg/ml aprotinin and leupeptin) or modified RIPA buffer (20 mM Tris (pH 7.4), 120 mM NaCl, 1% Triton X-100, 0.5% deoxycholate, 0.1% SDS, 10% glycerol, 5 mM EDTA, 50 mM sodium fluoride 1 mM Na3VO4, and 10 µg/ml aprotinin and leupeptin).

Kinase assay

Fyn immunoprecipitates were prepared from 200–300 µg of RIPA lysates using anti-Fyn (FYN 3-G; Santa Cruz Biotechnology). These were used in in vitro kinase assays as previously described (7) and were immunoblotted with anti-Fyn Ab (BD Transduction Laboratories).

Isolation of a raft fraction

Raft fractions were prepared as previously described (45). In brief, 1 x 108 thymocytes were lysed with 0.5 ml of MBS (25 mM MES (pH 6.5), 150 mM NaCl, 1% Triton X-100, 5 mM EDTA, 2 mM Na3VO4, 50 mM sodium fluoride, 1 mM PMSF, and 10 µg/ml aprotinin and leupeptin), incubated on ice for 30–45 min, gently mixed with an equal volume of 80% sucrose (w/v) in MBS, and placed in the bottom of a clear tube (344062; Beckman Coulter). The samples were then overlaid with 2 ml of 30% sucrose and 1 ml of 5% sucrose in MBS and centrifuged at 40,000 rpm in a SW60 rotor for 16–18 h at 4°C. After centrifugation, nine fractions of 450 µl each were collected, starting at the top of the gradient. Equal aliquots of each fraction were resolved by SDS-PAGE for immunoblotting. For immunoprecipitation experiments, equal aliquots from fractions 3 and 4 (the lipid raft fractions) or from fractions 8 and 9 (the Triton X-100-soluble fractions) were combined. The lipid raft pool was incubated with 20 mM n-octyl {beta}-glucopyranoside for 1 h before immunoprecipitation.

COS cell transfection

COS-1 cells were transfected with 4 µg of plasmid expressing wild-type (WT) or mutant Fyn (46) with or without 2 µg of plasmid expressing WT PTP{alpha} or inactive mutant PTP{alpha}-C414S/C704S (6), using Lipofectamine reagent (Invitrogen Life Technologies). Twenty-four hours after transfection, cells were lysed in modified RIPA buffer.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
PTP{alpha}–/– T cells

PTP{alpha} is readily detectable in thymocytes and splenocytes of WT mice, albeit at lower levels than in brain (Fig. 1A). CD45 is a major transmembrane PTP of nucleated hemopoietic cells that plays a key role in T cell development and activation (47). CD45 expression was not altered in PTP{alpha}-null thymocytes or splenocytes (Fig. 1A). T cell development appeared normal in PTP{alpha}–/– mice; there were equivalent populations of CD4 and CD8a single-positive and CD4/CD8a double-negative and double-positive cells (Fig. 1B) and similar expressions of CD25 and CD69 (data not shown) in the thymi and spleens of these and WT mice. The sizes and cellularity of these tissues did not significantly differ in WT and PTP{alpha}-deficient mice (data not shown).



View larger version (41K):
[in this window]
[in a new window]
  		FIGURE 1. Expression of selected proteins in PTP{alpha}-deficient thymocytes and splenocytes. A, Lysates of thymocytes (thy), splenocytes (spl), and brain from WT (+/+) and PTP{alpha}–/– (–/–) mice were probed for PTP{alpha}, CD45, and {beta}-actin. B, Thymocytes and spleen cells from WT and PTP{alpha}–/– mice were analyzed by flow cytometry for surface expression of CD4 and CD8a. A representative flow cytometric analysis is shown. Numbers in each quadrant are the average percentage of cells that were positive for either, both, or neither of these molecules as determined from three age-matched pairs of WT and PTP{alpha}–/– mice. There were no statistically significant differences between these averages (±SD) from any cell subpopulation.

 
Protein tyrosine phosphorylation in PTP{alpha}–/– thymocytes

An early event upon TCR engagement is increased protein tyrosine phosphorylation that is initially mediated through the activities of the SFKs Lck and Fyn. This response was examined in WT and PTP{alpha}–/– thymocytes. Anti-CD3{epsilon}-induced phosphorylation of proteins of ~120, 55, 42, and 20 kDa was observed in both WT and PTP{alpha}–/– cells (Fig. 2A). The phosphotyrosine content of the ~120-kDa protein 1 and 10 min after stimulation was somewhat less in the PTP{alpha}–/– cells, and those of the ~55- and ~20-kDa proteins were elevated and disappeared more rapidly in stimulated PTP{alpha}–/– cells. Equivalent ERK activation was detected in WT and PTP{alpha}–/– cells (Fig. 2B). However, the major difference observed was between unstimulated WT and PTP{alpha}–/– thymocytes, with a dramatically increased phosphorylation of a band(s) of ~75–80 kDa and a lesser increase in ~60- and 120-kDa bands observed in the PTP{alpha}–/– cells (Fig. 2A, arrows). Zap70 and LAT were not detectably phosphorylated in the unstimulated PTP{alpha}–/– cells (data not shown). The p75–80 tyrosine phosphorylation was reduced in response to anti-CD3{epsilon} stimulation of PTP{alpha}–/– cells, whereas in WT cells, p75–80 tyrosine phosphorylation rapidly increased upon anti-CD3{epsilon} stimulation and was maintained at a high level for at least 10 min.



View larger version (59K):
[in this window]
[in a new window]
  		FIGURE 2. TCR-stimulated protein tyrosine phosphorylation in PTP{alpha}–/– thymocytes. WT (+/+) and PTP{alpha}–/– (–/–) thymocytes were left unstimulated (0) or were stimulated with anti-CD3{epsilon} Ab for the indicated times (minutes). Cell lysates were probed for phosphotyrosine (top panel), PTP{alpha} (middle panel), or {beta}-actin (bottom panel) in A, or were probed for phospho-Erk1/2 (top panel) and for Erk1/2 (bottom panel) in B.

 
Fyn activity is increased in resting PTP{alpha}–/– thymocytes

PTP{alpha}-deficient mice exhibit reduced Src and Fyn activity in brain and embryonic fibroblasts, indicating that PTP{alpha} is a positive regulator of these Src family kinases (7, 8). We thus investigated the activity of Fyn, a Src family kinase that is involved in very early events of TCR signaling, in resting and stimulated PTP{alpha}–/– thymocytes. Fyn activity was significantly elevated in unstimulated PTP{alpha}–/– cells compared with WT cells (1.64 ± 0.1 vs 1 U, respectively; p < 0.05), as assessed by Fyn immunoprecipitation and in vitro kinase assays (Fig. 3A, top panel, and B). Anti-CD3{epsilon} stimulation initially increased the low basal Fyn activity in WT cells, but progressively reduced the high basal Fyn activity in PTP{alpha}–/– thymocytes (Fig. 3, A and B). Thus, despite very different Fyn activities in resting WT and PTP{alpha}–/– thymocytes, the Fyn activities in both cell types after anti-CD3{epsilon} stimulation were similar. This closely parallels the protein tyrosine phosphorylation patterns in these cells and suggests that the enhanced Fyn activity in resting PTP{alpha}–/– thymocytes may be the cause of the enhanced tyrosine phosphorylation of certain proteins, such as that of those represented by p75–80.



View larger version (37K):
[in this window]
[in a new window]
  		FIGURE 3. Fyn activity and phosphorylation in PTP{alpha}–/– thymocytes. WT (+/+) and PTP{alpha}–/– (–/–) thymocytes were left unstimulated (0) or were stimulated with anti-CD3{epsilon} Ab for the indicated times (minutes). A, Fyn was immunoprecipitated from the cell lysates and assayed for in vitro kinase activity (top panel) or probed for phosphotyrosine content (middle panel) and Fyn amount (bottom panel). B, Densitometric quantification of Fyn autophosphorylation in in vitro kinase assays and phosphotyrosine content of immunoprecipitated Fyn (as in A), both expressed per unit of Fyn protein, is shown, with the bars ({cjs2108}, WT; {blacksquare}, PTP{alpha}–/–) representing the mean ± SD (n = 3). Kinase activity was significantly different between unstimulated WT and PTP{alpha}–/– thymocytes (**, p < 0.0005; *, p < 0.05). C, Fyn immunoprecipitates were also probed with anti-Src phosphosite-specific Abs that recognize the indicated phosphorylated tyrosine residues in Fyn and for Fyn amount. D, The results of four independent experiments, as in C, were quantified by densitometric scanning. Bars ( {permzspch020}, WT; {blacksquare}, PTP{alpha}–/–) represent the mean Fyn phosphorylation at Tyr528 and Tyr417 after equalization for Fyn amount ± SD. Fyn phosphorylation at both sites was significantly (**, p < 0.0005) different in unstimulated thymocytes. E, Fyn immunoprecipitates from unstimulated WT and PTP{alpha}–/– thymocytes from four pairs of mice were probed with the indicated phosphosite-specific Abs and for Fyn. The calculated ratios of phospho-Fyn per unit of Fyn are shown below the autoradiographs.

 
Investigation of Fyn tyrosine phosphorylation status showed that the phosphotyrosine content of Fyn was elevated in unstimulated PTP{alpha}–/– thymocytes compared with WT cells (Fig. 3A, middle panel, and B). PTP{alpha} can dephosphorylate the regulatory C-terminal Tyr528 of Fyn (6), and in accord with this, we observed that at least part of the increased phosphotyrosine content of Fyn in PTP{alpha}–/– thymocytes was due to ~40% increased phosphorylation at Tyr528 (Fig. 3, C–E). Phosphorylation at Tyr417 in the activation loop of Fyn was also increased by ~70% in the PTP{alpha}–/– cells (Fig. 3, C–E). This suggests that PTP{alpha} can dephosphorylate both phosphorylation sites on Fyn, with an overall effect of reducing Fyn activity in unstimulated thymocytes. In contrast, no significant differences in Fyn Tyr528 or Tyr417 phosphorylation were detected between anti-CD3-stimulated WT and PTP{alpha}–/– thymocytes (Fig. 3, C and D).

Heterologously expressed WT and mutant forms of FynB and FynT were used to verify the specificity of phosphosite-specific Abs raised to the C-terminal and autophosphorylation sites of Src (Fig. 4A). There was some residual detection of FynB-K299M, an inactive Fyn mutant that cannot autophosphorylate at Y417, by the phospho-Y417-specific Ab (anti-Src pTyr418). Similarly, we observed residual detection of FynB-Y528F and FynT-Y528F, forms of Fyn possessing a Phe substitution at Tyr528 (FynT-Y528F) that eliminates the C-terminal tail phosphorylation site, by the phospho-Y528 Ab (anti-Src pTyr529). However, these signals were minor compared with those detected for Fyn possessing the appropriately phosphorylated tyrosine residue. Thus, these Abs can be used to detect the two phosphoforms of Fyn in WT and PTP{alpha}–/– thymocytes as in the experiments shown in Fig. 3. In addition, these Abs were used in PTP{alpha}/Fyn cotransfection experiments to confirm that PTP{alpha} could indeed dephosphorylate Fyn-Tyr417, because this specificity of PTP{alpha} has not been previously reported. Probing FynT immunoprecipitates for total phosphotyrosine content showed that PTP{alpha}, but not a catalytically inactive PTP{alpha} mutant, dephosphorylated FynT or FynT-Y528F (Fig. 4, B–D). Probing with phosphosite-specific Abs verified that both FynT and FynT-Y528F were dephosphorylated at Tyr417 in the presence of PTP{alpha}, and as expected, FynT was also dephosphorylated at Tyr528 (Fig. 4, B–D).



View larger version (33K):
[in this window]
[in a new window]
  		FIGURE 4. PTP{alpha} dephosphorylates FynT. A, Fyn immunoprecipitates were prepared from lysates of untransfected (untr) COS cells or COS cells expressing WT (wt) or the indicated mutant forms of FynB or FynT, and probed with Abs to Fyn (upper panel) or to the indicated phosphorylated site on Fyn. B, As in A, except that the cells were transfected with plasmids expressing FynT or FynT-Y528F, alone or together with WT ({alpha}-wt), or catalytically inactive ({alpha}-mt) mutant PTP{alpha}. The immunoprecipitates were probed for Fyn, phosphotyrosine, and phosphorylation at Tyr417 and Tyr528 as indicated. The amount of PTP{alpha} in each cell lysate is shown in the top panels. C and D, The results from B and two other independent experiments were quantified by densitometric scanning. The bars ({square}, no coexpressed PTP{alpha}; {permzspch020}, WT PTP{alpha}; {blacksquare}, catalytically inactive mutant PTP{alpha}) represent the average overall and site-specific phosphorylation of FynT (C) and FynT-Y528F (D) ± SD, as indicated below each graph.

 
PTP{alpha} is present in thymocyte cell lipid rafts

Areas of the plasma membrane enriched in cholesterol and sphingolipids, termed lipid rafts, are believed to serve as signaling platforms in which T cell signaling proteins reside and to which other proteins are recruited upon TCR stimulation to form signaling complexes (42, 43). Because T cell Fyn is a likely PTP{alpha} substrate, and because a significant portion of Fyn in T cells is present in raft fractions (34, 48), we investigated whether PTP{alpha} was localized to lipid rafts. Fyn and Lck, together with LAT, an adaptor protein involved in TCR signaling that is targeted to lipid rafts (49), were present in raft fractions isolated from WT mouse thymocytes (Fig. 5). As reported previously (38, 50), a small population of the receptor PTP CD45 was detected in raft fractions, with the majority of the CD45 localizing to nonraft fractions. Similar to CD45, a small amount of PTP{alpha} was present in raft fractions, with most PTP{alpha} segregating in the nonraft, Triton X-100-soluble fractions (Fig. 5). The transferrin receptor is reported to be a Triton X-100-soluble membrane protein (51, 52) and was indeed exclusively detected in nonraft fractions of thymocytes (Fig. 5), indicating that the presence of CD45 and PTP{alpha} in raft fractions was not due to contamination of these fractions with detergent-soluble material.



View larger version (48K):
[in this window]
[in a new window]
  		FIGURE 5. PTP{alpha} is present in thymocyte lipid rafts. Mouse thymocyte lysates in 1% Triton X-100-containing buffer were subjected to sucrose density gradient centrifugation. Fractions were removed, beginning at the top of the tube with fraction 1, and were probed for the indicated proteins (Tr-R, transferrin receptor). Fractions 3 and 4 contain lipid rafts, as evidenced by the presence of the known raft proteins Fyn, Lck, and LAT.

 
Fyn activity is increased in raft fractions of PTP{alpha}–/– thymocytes

Populations of PTP{alpha} and Fyn are present in raft and nonraft thymocyte fractions. We therefore assessed the activities of both pools of Fyn from WT and PTP{alpha}–/– thymocytes. Raft-associated Fyn was twice as active in unstimulated PTP{alpha}–/– cells as in WT cells (Fig. 6, A and C). Anti-CD3{epsilon} stimulation of PTP{alpha}–/– cells reduced Fyn activity in rafts. In WT cells, anti-CD3{epsilon} treatment increased Fyn activity in the raft fractions (Fig. 6, A and C). In contrast, anti-CD3{epsilon} induced little to no changes in nonraft Fyn activity in WT and PTP{alpha}–/– thymocytes (Fig. 6B). These results indicate that TCR stimulation in these cells is mainly linked to raft Fyn activation. They also suggest that PTP{alpha} differentially regulates the activity of lipid raft-associated and nonraft-localized Fyn populations, with preferential and significant inhibitory effects on Fyn in lipid rafts.



View larger version (32K):
[in this window]
[in a new window]
  		FIGURE 6. Fyn kinase activity in raft and nonraft thymocyte fractions. WT (+/+) and PTP{alpha}–/– (–/–) thymocytes were left unstimulated (0) or were stimulated with anti-CD3{epsilon} Ab for the indicated times (minutes) before lysis. Raft and nonraft fractions were isolated by sucrose density centrifugation. Fyn immunoprecipitates were prepared from raft (pooled fractions 3 and 4; A) or nonraft (pooled fractions 8 and 9; B) samples, used in in vitro kinase assays (top panels), and probed for Fyn amount (bottom panels). C, Fyn autophosphorylation per Fyn amount was quantified by densitometric scanning of the results shown in A and from two other such experiments. Bars represent the kinase activity of Fyn (mean ± SD) in raft fractions from WT ( {permzspch020}) and PTP{alpha}–/– ({blacksquare}) thymocytes. Kinase activity was significantly different between unstimulated WT and PTP{alpha}–/– thymocytes (*, p < 0.0005). Similar results were obtained when enolase phosphorylation per Fyn amount was quantified (data not shown).

 
Cbp/PAG is hyperphosphorylated in PTP{alpha}–/– thymocytes

Cbp/PAG is a transmembrane protein localized in lipid rafts (36, 37). Tyrosine-phosphorylated Cbp/PAG recruits Csk, a tyrosine kinase that phosphorylates and negatively regulates Src family kinases, to rafts. The roles of PTP{alpha} and Cbp/PAG-Csk as Src family kinase regulators prompted us to investigate whether Cbp/PAG phosphorylation and association with Csk were altered in thymocytes lacking PTP{alpha}. Probing raft fractions of PTP{alpha}–/– samples with anti-phosphotyrosine Ab detected enhanced phosphorylation of a band that comigrated with Cbp/PAG (Fig. 7A). In accord with this, more Csk was present in the lipid raft fractions of PTP{alpha}–/– cells than of WT cells (Fig. 7A, bottom panels). To confirm these observations, Cbp/PAG immunoprecipitates from WT and PTP{alpha}-deficient thymocytes were probed for phosphotyrosine, revealing increased Cbp/PAG phosphorylation in the absence of PTP{alpha}–/– (Fig. 7B). An increased amount of Csk was associated with the hyperphosphorylated Cbp/PAG in PTP{alpha}–/– cells (Fig. 7B).



View larger version (35K):
[in this window]
[in a new window]
  		FIGURE 7. Cbp/PAG hyperphosphorylation and enhanced association with Csk in PTP{alpha}–/– thymocytes. Unstimulated WT (+/+) and PTP{alpha}–/– (–/–) thymocytes were lysed. A, The lysates were resolved by sucrose density centrifugation. Raft fractions (fractions 3 and 4) and adjacent fractions (2 and 5) were probed with anti-phosphotyrosine Ab (top panels), then stripped and reprobed for Cbp/PAG (middle panels). The same fractions were independently probed for Csk (bottom panels). Cbp/PAG comigrated with the phosphotyrosyl-positive band of ~75 kDa that was detected in the upper panels (right arrow). B, Cbp/PAG was immunoprecipitated from thymocyte lysates and probed for phosphotyrosine (top panel), associated Csk (middle panel), and Cbp/PAG (bottom panel).

 
PTP{alpha} is not required for TCR-stimulated Cbp/PAG dephosphorylation

TCR stimulation induces rapid tyrosine dephosphorylation of Cbp/PAG (36, 41). To determine whether PTP{alpha} plays a role in this process, the Cbp/PAG phosphorylation status was determined in PTP{alpha}–/– cells after anti-CD3{epsilon} treatment. Although Cbp/PAG in unstimulated PTP{alpha}–/– thymocytes was highly phosphorylated, it was rapidly dephosphorylated upon stimulation (Fig. 8A). By 1 min of stimulation, only minimal tyrosine phosphorylation of Cbp/PAG was detectable in PTP{alpha}–/– cells, and this was similar to that in stimulated WT cells. In both cell types, Cbp/PAG remained dephosphorylated for at least 10 min after stimulation. Thus, PTP{alpha} is not required for efficient TCR-stimulated Cbp/PAG dephosphorylation.



View larger version (44K):
[in this window]
[in a new window]
  		FIGURE 8. Cbp/PAG dephosphorylation is not perturbed in PTP{alpha}–/– thymocytes. A, WT (+/+) and PTP{alpha}–/– (–/–) thymocytes were left unstimulated (0) or were stimulated with anti-CD3{epsilon} Ab for the indicated times (minutes) before lysis. Cbp/PAG immunoprecipitates were probed for phosphotyrosine content (top panel), Csk (middle panel), and Cbp/PAG (bottom panel). B, Unstimulated PTP{alpha}–/– thymocytes were left untreated (0) or were treated with 10 µM PP2 or PP3 for the indicated times. The cells were then lysed, and Cbp/PAG immunoprecipitates were probed for phosphotyrosine (top panels), Csk (middle panels), or Cbp/PAG (bottom panels). C, As in B, except that CD45-deficient Jurkat cells were used.

 
Cbp/PAG hyperphosphorylation in resting PTP{alpha}–/– thymocytes is not due to the absence of PTP{alpha}-mediated Cbp/PAG dephosphorylation

Cbp/PAG is phosphorylated by SFKs (36, 37, 48). The enhanced Cbp/PAG phosphorylation observed in resting thymocytes lacking PTP{alpha} could be due to increased activity of Fyn and/or a reduction in Cbp/PAG phosphatase activity, with PTP{alpha} being a potential Cbp/PAG phosphatase in unstimulated cells. To distinguish between these possibilities, PTP{alpha}–/– cells were incubated with the Src family kinase inhibitor PP2 or the inactive analog PP3, and Cbp/PAG phosphorylation was monitored by immunoprecipitation and probing with anti-phosphotyrosine Ab. If Cbp/PAG hyperphosphorylation in PTP{alpha}–/– thymocytes is a consequence of higher Fyn activity, PP2-mediated inhibition of Fyn would allow any Cbp/PAG phosphatase activity to predominate, and Cbp/PAG dephosphorylation would be predicted to occur. However, if, in addition to its role as a regulator of Fyn, PTP{alpha} functioned as a Cbp/PAG phosphatase, the predicted Cbp/PAG dephosphorylation could not occur in the cells lacking PTP{alpha}. As shown in Fig. 8B, PP2, but not PP3, treatment of unstimulated PTP{alpha}–/– thymocytes resulted in reduced Cbp/PAG phosphorylation, consistent with an endogenous phosphatase activity that is manifested upon blockade of Src family kinase action. This suggests that enhanced Cbp/PAG phosphorylation in PTP{alpha}–/– thymocytes is primarily due to the loss of the negative regulatory action of PTP{alpha} on Fyn, rather than to the loss of a direct action of PTP{alpha} on Cbp/PAG as a phosphatase.

Cbp/PAG phosphorylation is also elevated in T cells lacking CD45 (38). To determine whether CD45 functions as a Cbp/PAG phosphatase in unstimulated T cells, thus potentially acting in this manner in PP2-treated PTP{alpha}–/– thymocytes, the CD45-negative Jurkat cell line J45.01 was treated with PP2, and Cbp/PAG tyrosine phosphorylation was monitored. As shown in Fig. 8C, the inhibition of SFK resulted in Cbp/PAG dephosphorylation and significantly reduced association with Csk. Treatment of the same cells with the control compound PP3 had no effect on these parameters. Thus, the enhanced Cbp/PAG phosphorylation observed in T cells lacking CD45 or PTP{alpha} is not due to the lack of direct dephosphorylation of Cbp/PAG by either of these PTPs.

Impaired PTP{alpha}–/– T cell proliferation

To determine whether PTP{alpha} is involved in long-term parameters of T cell activation, the proliferative ability of PTP{alpha}–/– thymocytes was tested. Purified CD3+ and CD4+ cells lacking PTP{alpha} proliferated less well than WT cells in response to anti-CD3{epsilon} stimulation (Fig. 9, A and C). Costimulation with either anti-CD28 or PMA increased proliferation, but PTP{alpha}–/– thymocytes still responded less well than WT cells. Stimulation with PMA and the calcium ionophone ionomycin resulted in equivalent proliferation of WT and PTP{alpha}–/– mutant cells. The above stimulations involving anti-CD3 also elicited reduced IL-2 production by PTP{alpha}–/– thymocytes compared with WT cells (Fig. 9, B and D). Costimulation with PMA and ionomycin resulted in equivalent IL-2 production by WT and PTP{alpha}-deficient cells. These results demonstrate that the proliferative and IL-2 production capabilities of thymocytes lacking PTP{alpha} are intact. However, PTP{alpha} is specifically required for efficient TCR-stimulated proliferation and IL-2 synthesis. In contrast, no defects in proliferation or IL-2 production were detected in stimulated lymph node T cells from WT and PTP{alpha}–/– animals (Fig. 9, E and F). Consistent with this, protein tyrosine phosphorylation profiles were similar in PTP{alpha}–/– and WT lymph node T cells before and after anti-CD3{epsilon} stimulation (Fig. 10A). Furthermore, Fyn tyrosine phosphorylation and activity were unaltered in lymph node T cells by ablation of PTP{alpha} (Fig. 10B). This suggests that PTP{alpha} is not involved in Fyn regulation in resting peripheral T cells or in TCR-mediated signaling in these cells.



View larger version (38K):
[in this window]
[in a new window]
  		FIGURE 9. Impaired PTP{alpha}–/– thymocyte proliferation and IL-2 production. Purified CD3+ (A and B) or CD4+CD8– (C and D) thymocyte populations or lymph node T cells (E and F) from WT ( {permzspch020}) and PTP{alpha}–/– ({blacksquare}) mice were plated in 96-well plates coated with the indicated Abs (anti-CD3 and anti-CD28) and/or containing coactivators (PMA and ionomycin). A, C, and E, At 48 h, [3H]thymidine was added to the medium and incubated overnight. Cells were washed and harvested, and [3H]thymidine incorporation (cpm) was quantified. The bars ± SD represent the average cpm from six wells. B, D, and F, At 48 h, the medium from other replicate wells was removed and used to assay IL-2 content. The bars represent the average IL-2 concentration ± SD from triplicate wells.

 


View larger version (43K):
[in this window]
[in a new window]
  		FIGURE 10. Protein tyrosine phosphorylation and Fyn phosphorylation/activity are not altered in resting or stimulated PTP{alpha}–/– lymph node T cells. WT (+/+) and PTP{alpha}–/– (–/–) lymphocytes from lymph nodes (LN) were left unstimulated or were stimulated with anti-CD3{epsilon} Ab for the indicated times (minutes). A, Cell lysates were probed for phosphotyrosine (top panel), PTP{alpha} (middle panel), and {beta}-actin (bottom panel). B, Fyn immunoprecipitates from these cells and from unstimulated WT and PTP{alpha}–/– thymocytes (Th) were probed for phosphotyrosine content and Fyn amount (top panels). Immunoprecipitated Fyn from lymph node T cells was also assayed for in vitro kinase activity (bottom panels).

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
Our investigation of a potential role for PTP{alpha} in T cells has revealed several differences linked to regulated protein tyrosine phosphorylation in unstimulated PTP{alpha}–/– mouse thymocytes compared with WT mouse thymocytes. First, PTP{alpha}–/– thymocytes exhibited enhanced tyrosine phosphorylation of several proteins. Second, Fyn phosphorylation and activity were higher in the PTP{alpha}–/– cells. Third, the phosphorylation of Cbp/PAG, an Src family kinase substrate, was increased in the absence of PTP{alpha}. Thus, Fyn and Cbp/PAG constitute two hyperphosphorylated proteins in resting PTP{alpha}–/– thymocytes. In contrast to these alterations, no remarkable differences in protein tyrosine phosphorylation profiles or in Fyn activities were detected after anti-CD3-stimulation of PTP{alpha}-deficient thymocytes compared with WT thymocytes. Although not ruling out the possibility that PTP{alpha} is involved in TCR-stimulated signaling events, these results strongly suggest an important role for PTP{alpha} in regulating tyrosine phosphorylation in thymocytes before TCR activation.

The elevated protein tyrosine phosphorylation in unstimulated PTP{alpha}–/– thymocytes indicates that the absence of PTP{alpha} skews the basal control of phosphorylation, either through a lack of PTP{alpha}-mediated protein dephosphorylation or by increasing tyrosine kinase activity. Consistent with the latter possibility, the kinase activity of Fyn was elevated in PTP{alpha}-deficient thymocytes. PTP{alpha}, therefore, seems to function in resting thymocytes as a negative regulator of Fyn. This is in contrast to its role in brain and mouse embryo fibroblasts as a positive regulator of Src and Fyn (7, 8). Clearly, Src and Fyn activities were reduced in PTP{alpha}–/– brain and fibroblasts, in conjunction with increased phosphorylation of the negative regulatory C-terminal tyrosine residue. However, Fyn from PTP{alpha}–/– thymocytes possessed higher Fyn activity and increased phosphotyrosine content due to enhanced phosphorylation at the C-terminal negative regulatory Tyr528 site and at the positive regulatory Tyr417 site in the activation loop. Conversely, reduced FynT Tyr528 and Tyr417 phosphorylation occurred upon coexpression with PTP{alpha} in COS cells. These findings suggest that PTP{alpha} can act as either a positive or a negative regulator of thymocyte Fyn. In PTP{alpha}–/– thymocytes, elevated Tyr417 phosphorylation probably predominates to effect Fyn activation, as is the case with and has been discussed for Lck in CD45–/– mouse thymocytes (53). In studies that directly measured Lck activity and phosphorylation status in CD45–/– thymocytes, the kinase activity of Lck was increased 2- to 4-fold, and Lck was hyperphosphorylated on negative (Tyr505) and positive (Tyr394) regulatory residues (31, 32, 54). Fyn activity and its phosphorylation status at specific sites have not been reported in CD45–/– thymocytes, but, like Lck, the overall tyrosine phosphorylation of Fyn is increased by ~2-fold (54). As we observed in PTP{alpha}–/– thymocytes, the basal tyrosine phosphorylation of certain proteins is also increased in CD45–/– thymocytes (31, 54). Our results indicate that PTP{alpha} and CD45 regulate SFK activity, at least in unstimulated thymocytes, in similar ways and with comparable magnitudes.

A consequence of the loss of PTP{alpha} is hyperphosphorylation of Cbp/PAG. This enhances the interaction of Cbp/PAG with Csk, mediated through recognition by the Csk SH2 domain of phospho-Tyr314 of Cbp/PAG (36, 37). Inhibiting SFK activity by PP2 treatment of PTP{alpha}–/– thymocytes permits a rapid dephosphorylation of Cbp/PAG and abrogates Csk binding to Cbp/PAG, demonstrating that increased Cbp/PAG phosphorylation in the PTP{alpha}–/– cells is probably a consequence of Fyn activation rather than due to the absence of PTP{alpha}-mediated Cbp/PAG dephosphorylation. Indeed, Fyn can phosphorylate Cbp/PAG (36) and appears to be responsible for most Cbp/PAG phosphorylation, because this is greatly reduced in Fyn–/– T cells (48). Some Cbp/PAG tyrosine phosphorylation is maintained during SFK inhibition in PTP{alpha}–/– thymocytes. This indicates either that PTP{alpha} acts as a phosphatase on these sites or that TCR engagement activates a specific PTP that is not constitutively functional in resting cells. The latter possibility seems most likely, because the residual level of Cbp/PAG phosphorylation and the low amount of still detectable bound Csk approximate those in unstimulated WT cells where PTP{alpha} is present. TCR stimulation induces rapid and considerable dephosphorylation of Cbp/PAG (36, 41), and this is not altered in PTP{alpha}–/– cells. Together, our results indicate that PTP{alpha} is not a Cbp/PAG phosphatase in resting or stimulated thymocytes.

Cbp/PAG phosphorylation is also increased in unstimulated CD45–/– thymocytes and in a T cell line lacking CD45 (38). As in PTP{alpha}–/– thymocytes, this appears to be due to increased SFK activity rather than to a lack of CD45-mediated Cbp/PAG dephosphorylation, because ablation of SFK activity by PP2 treatment of CD45–/– Jurkat cells results in Cbp/PAG dephosphorylation (Fig. 8C and Ref.36). However, unlike PTP{alpha}, CD45 does play a role in anti-CD3 stimulated Cbp/PAG dephosphorylation, because this is inhibited in CD45–/– thymocytes (38). This difference might contribute to the more severely impaired TCR-mediated signaling and proliferation of T cells lacking CD45 (54, 55, 56, 57, 58, 59) than of those lacking PTP{alpha}.

CD45 is an abundant membrane protein of T cells and is a key regulator of Lck and Fyn. Nevertheless, CD45 cannot compensate for the lack of PTP{alpha} as a regulator of Fyn activity in resting thymocytes, highlighting an unsuspected and unique action of PTP{alpha} on Fyn in these cells. Conversely, PTP{alpha} cannot compensate for CD45 function in T cells, as is obvious from the major defects in thymocyte development observed in CD45-deficient mice and the severely impaired proliferation of CD45–/– thymocytes upon TCR engagement (54, 58, 59, 60). Although this could be due to what are probably much lower amounts of PTP{alpha} than of CD45 in T cells or to a lower specific activity of PTP{alpha} than CD45 (61), these factors cannot account for the inability of CD45 to compensate for the absence of PTP{alpha}. Generally, CD45-null mice share some T cell developmental and proliferation defects with mice lacking Lck, whereas PTP{alpha}–/– mice are more similar to mice lacking Fyn in having normal T cell development and less severely impaired proliferation. Perhaps this reflects relatively greater contributions of CD45 to Lck regulation and of PTP{alpha} to Fyn regulation. It is also possible that CD45 and PTP{alpha} regulate different populations of Fyn that are distinguished by the localization of various phosphatase- kinase pools within the T cell. Increased Fyn activity in PTP{alpha}–/– thymocytes is specific to the pool of Fyn associated with detergent-insoluble lipid rafts. Our preliminary results do not reveal differences in Lck activity in PTP{alpha}–/– and WT thymocytes (data not shown). Notably, Fyn and Lck have overlapping, yet distinct, subcellular localizations in resting T cells, with most Lck segregated outside lipid rafts, in contrast to the preferential presence of Fyn in raft microdomains (34, 35). We have shown that a subpopulation of PTP{alpha} is present in raft T cell fractions; however, so is some CD45. Conceivably, additional factors such as the interaction of PTP{alpha} or CD45 with other raft proteins could determine the abilities of these PTPs to regulate raft SFKs. For example, CD45 activity toward Lck can be enhanced by the isoform-specific association of CD45 with CD4 (62). PTP{alpha} can form a complex with contactin, a GPI-linked cell surface molecule of neuronal cells (63). GPI-anchored proteins are typical components of lipid rafts (64, 65), indicating the potential for PTP{alpha} to interact with other raft receptor molecules in T cells.

Our study also reveals a novel role for PTP{alpha} in TCR-stimulated thymocyte proliferation. Anti-CD3, alone or with costimulators, induced significantly less proliferation and reduced IL-2 production by PTP{alpha}–/– thymocytes compared with WT cells. In contrast, proliferation and IL-2 production were normal in PTP{alpha}–/– T cells from lymph nodes, suggesting that PTP{alpha} is not essential for these TCR-mediated responses in peripheral T cells. Furthermore, Fyn in resting PTP{alpha}–/– lymph node T cells was not hyperphosphorylated or activated compared with that in WT lymph node T cells. Studies of Fyn–/– T cells have found that Fyn is required for optimal TCR-stimulated thymocyte, but not splenic T cell, proliferation (11, 13). Our results are consistent with PTP{alpha} acting as a Fyn regulator, with functional effects on TCR responses in thymocytes, but not in mature peripheral T cells.

The impaired proliferation of thymocytes lacking Fyn reflects a requirement for functional Fyn for optimal proliferation-linked signaling events. In contrast, Fyn is hyperactive in PTP{alpha}–/– thymocytes before treating the cells with proliferation stimuli, yet proliferation is also impaired. This is reminiscent of the defective TCR-mediated responses of thymocytes with hyperactive Lck before TCR stimulation (CD45–/–) (54) and of thymocytes and peripheral T cells lacking Lck (12, 15). Like PTP{alpha}–/– thymocytes, CD45–/– cells also possess hyperphosphorylated Cbp/PAG (38). In unstimulated CD45–/– and PTP{alpha}–/– thymocytes, this may be a down-regulatory mechanism to reduce the elevated Lck and Fyn activities. Thus, although Lck and Fyn are physically and functionally required for optimal TCR-induced proliferation, these observations indicate that these SFKs must be maintained at a lower activity or threshold state before TCR stimulation to function properly in subsequent TCR-linked responses. This is exemplified by the physiological situation in which thymocytes and other T cells become anergic after overstimulation or inappropriate stimulation, such as by anti-CD3 in the absence of costimulators. Interestingly, increased activity or expression of Fyn has been associated with anergy induction in T cells (66, 67, 68, 69), although the molecular mechanisms involved in anergization are not clear. It is possible, therefore, that the absence of PTP{alpha} results in inappropriate and constitutive activation of Fyn and perhaps of other proteins, leading to partial anergy or an anergic-like state of the thymocytes and subsequent hypoproliferative responses to TCR stimulation. Other mechanisms may be alternatively or additionally involved as well. For T cells to successfully proliferate, the early phosphorylation and/or activation of multiple signaling proteins are required. The absence of critical regulators, such as CD45 and Lck (i.e., CD45–/– or Lck–/– T cells), results in a dramatic block of TCR-proximal phosphorylation/activation events. In contrast, the absence of other proteins linked to TCR-mediated activation, such as Fyb/Slap/ADAP (adhesion and degranulation promoting adaptor protein) (70, 71) or EphB6 (72), and as we report in this study, PTP{alpha}, does not impact these immediate events despite resulting in significant in vitro proliferative defects of the same T cells. Costimulatory and/or cell attachment-regulated signaling may contribute to differences between short- and long-term T cell activation parameters. For example, the absence of ADAP also profoundly affects TCR-stimulated, integrin-mediated adhesion (70, 71). Integrin receptors provide costimulatory signals to naive T cells by stabilizing contacts between the TCR and immobilized anti-CD3 Ab and decreasing the threshold for activation (73, 74, 75). Because PTP{alpha} positively regulates integrin signaling in fibroblasts (8, 9), it might play a role in Ag-mediated interactions between the TCR and T cell integrins as well. Additional investigation is required into the precise signaling interplay that compromises the proliferation of PTP{alpha}-null thymocytes.


   Acknowledgments
 
We thank Rusung Tan for critical reading of the manuscript and insightful comments, Jing Wang for care and maintenance of the mice, Gregor Reid for technical advice, and Pauline Johnson (University of British Columbia) for providing the JE6.1 and J45.01 Jurkat cells.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the National Cancer Institute of Canada (to A.V.) and the Canadian Institutes of Health Research (to A.V. and C.J.P.). L.M. is the recipient of a Bertram Hoffmeister Postdoctoral Fellowship, and H.T.L. is the recipient of a Graduate Studentship from the British Columbia Research Institute for Children’s and Women’s Health. A.V. is a Senior Investigator with the Canadian Institutes of Health Research and holds the Canada Research Chair in Signaling in the Immune System. C.J.P. is the recipient of an Investigatorship Award from the British Columbia Research Institute for Children’s and Women’s Health. Back

2 Address correspondence and reprint requests to Dr. Catherine J. Pallen, British Columbia Research Institute for Children’s and Women’s Health, 950 West 28th Avenue, Vancouver, British Columbia, Canada V5Z 4H4. E-mail address: cpallen{at}interchange.ubc.ca Back

3 Abbreviations used in this paper: PTP{alpha}, protein tyrosine phosphatase {alpha}; Csk, C-terminal Src kinase; LAT, linker for activation of T cell; SFK, Src family tyrosine kinase; SH2, Src homology 2; WT, wild type. Back

Received for publication May 20, 2005. Accepted for publication September 27, 2005.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Pallen, C. J.. 2003. Protein tyrosine phosphatase {alpha} (PTP{alpha}): a src family kinase activator and mediator of multiple biological effects. Curr. Top. Med. Chem. 7: 821-835.
  2. Zheng, X. M., Y. Wang, C. J. Pallen. 1992. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Nature 359: 336-339. [Medline]
  3. den Hertog, J., C. E. Pals, M. P. Peppelenbosch, L. G. Tertoolen, S. W. de Laat, W. Kruijer. 1993. Receptor protein tyrosine phosphatase {alpha} activates pp60c-src and is involved in neuronal differentiation. EMBO J. 12: 3789-3798. [Medline]
  4. Yang, L. T., K. Alexandropoulos, J. Sap. 2002. c-SRC mediates neurite outgrowth through recruitment of Crk to the scaffolding protein Sin/Efs without altering the kinetics of ERK activation. J. Biol. Chem. 277: 17406-17414. [Abstract/Free Full Text]
  5. Harder, K. W., N. P. Moller, J. W. Peacock, F. R. Jirik. 1998. Protein-tyrosine phosphatase {alpha} regulates src family kinases and alters cell-substratum adhesion. J. Biol. Chem. 273: 31890-31900. [Abstract/Free Full Text]
  6. Bhandari, V., K. L. Lim, C. J. Pallen. 1998. Physical and functional interactions between receptor-like protein tyrosine phosphatase PTP{alpha} and p59fyn. J. Biol. Chem. 273: 8691-8698. [Abstract/Free Full Text]
  7. Ponniah, S., D. Z. M. Wang, K. L. Lim, C. J. Pallen. 1999. Targeted disruption of the tyrosine phosphatase PTP{alpha} leads to constitutive downregulation of the kinases src and fyn. Curr. Biol. 9: 535-538. [Medline]
  8. Su, J., M. Muranjan, J. Sap. 1999. Receptor protein tyrosine phosphatase {alpha} activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Curr. Biol. 9: 505-511. [Medline]
  9. Zeng, L., X. Si, W. P. Yu, H. T. Le, K. P. Ng, R. M. H. Teng, K. Ryan, D. Z. M. Wang, S. Ponniah, C. J. Pallen. 2003. PTP{alpha} regulates integrin-stimulated FAK autophosphorylation and cytoskeletal rearrangement in cell spreading and migration. J. Cell Biol. 160: 137-146. [Medline]
  10. Hermiston, M. L., Z. Xu, R. Majeti, A. Weiss. 2002. Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J. Clin. Invest. 109: 9-14. [Medline]
  11. Appleby, M. W., J. A. Gross, M. P. Cooke, S. D. Levin, X. Qian, R. M. Permutter. 1992. Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn. Cell 70: 751-763. [Medline]
  12. Molina, T. J., K. Kishihara, D. P. Siderovski, W. van Ewjik, A. Narendran, E. Timms, A. Wakeham, C. J. Paige, K. U. Hartmann, A. Veillette, et al 1992. Profound block in thymocyte development in mice lacking p56lck. Nature 357: 161-164. [Medline]
  13. Stein, P. L., H. M. Lee, S. Rich, P. Soriano. 1992. pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 70: 741-750. [Medline]
  14. Straus, D. B., A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70: 585-593. [Medline]
  15. van Oers, N. S. C., N. Killen, A. Weiss. 1996. Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J. Exp. Med. 183: 1053-1062. [Abstract/Free Full Text]
  16. Chan, A. C., M. Iwashima, C. W. Turck, A. Weiss. 1992. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR {zeta} chain. Cell 71: 649-662. [Medline]
  17. Iwashima, M., B. A. Irving, N. S. van Oers, A. C. Chan, A. Weiss. 1994. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263: 1136-1139. [Abstract/Free Full Text]
  18. Wardenburg, J. B., C. Fu, J. K. Jackman, H. Flotow, S. E. Wilkinson, D. H. Williams, R. Johnson, G. Kong, A. C. Chan, P. R. Findell. 1996. Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function. J. Biol. Chem. 271: 19641-19644. [Abstract/Free Full Text]
  19. Zhang, W., J. Sloan-Lancaster, J. Kitchen, J. Trible, L. E. Samuelson. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links the T cell receptor to cellular activation. Cell 92: 83-92. [Medline]
  20. Jordan, M. S., A. L. Singer, G. A. Koretzky. 2003. Adaptors as central mediators of signal transduction in immune cells. Nat. Immunol. 4: 110-116. [Medline]
  21. Wilkinson, B., H. Wang, C. E. Rudd. 2004. Positive and negative adaptors in T-cell signalling. Immunology 111: 368-374. [Medline]
  22. Mustelin, T., K. M. Coggeshall, A. Altman. 1989. Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase. Proc. Natl. Acad. Sci. USA 86: 6302-6306. [Abstract/Free Full Text]
  23. Ostergaard, H. L., D. A. Shackelford, T. R. Hurley, P. Johnson, R. Hyman, B. M. Sefton, I. S. Trowbridge. 1989. Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc. Natl. Acad. Sci. USA 86: 8959-8963. [Abstract/Free Full Text]
  24. Mustelin, T., A. Altman. 1990. Dephosphorylation and activation of the T cell tyrosine kinase pp56lck by the leukocyte common antigen (CD45). Oncogene 5: 809-813. [Medline]
  25. Cahir McFarland, E. D., T. R. Hurley, J. T. Pingel, B. M. Sefton, A. Shaw, M. L. Thomas. 1993. Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc. Natl. Acad. Sci. USA 90: 1402-1406. [Abstract/Free Full Text]
  26. Hurley, T. R., R. Hyman, B. M. Sefton. 1993. Differential effects of expression of the CD45 tyrosine protein phosphatase on the tyrosine phosphorylation of the lck, fyn, and c-src tyrosine protein kinases. Mol. Cell. Biol. 13: 1651-1656. [Abstract/Free Full Text]
  27. Burns, C. M., K. Sakaguchi, E. Appella, J. D. Ashwell. 1994. CD45 regulation of tyrosine phosphorylation and enzyme activity of src family kinases. J. Biol. Chem. 269: 13594-13600. [Abstract/Free Full Text]
  28. D’Oro, U., K. Sakaguchi, E. Appella, J. D. Ashwell. 1996. Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity. Mol. Cell. Biol. 16: 4996-5003. [Abstract]
  29. Pingel, S., M. Baker, M. Turner, N. Holmes, D. R. Alexander. 1999. The CD45 tyrosine phosphatase regulates CD3-induced signal transduction and T cell development in recombinase-deficient mice: restoration of pre-TCR function by active p56lck. Eur. J. Immunol. 29: 2376-2384. [Medline]
  30. Seavitt, J. R., L. S. White, K. M. Murphy, D. Y. Loh, R. M. Perlmutter, M. L. Thomas. 1999. Expression of the p56Lck Y505F mutation in CD45-deficient mice rescues thymocyte development. Mol. Cell. Biol. 19: 4200-4208. [Abstract/Free Full Text]
  31. Baker, M., J. Gamble, R. Tooze, D. Higgins, F. T. Yang, P. C. O’Brien, N. Coleman, S. Pingel, M. Turner, D. R. Alexander. 2000. Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutant lck mice. EMBO J. 19: 4644-4654. [Medline]
  32. D’Oro, U., J. D. Ashwell. 1999. Cutting edge: the CD45 tyrosine phosphatase is an inhibitor of Lck activity in thymocytes. J. Immunol. 162: 1879-1883. [Abstract/Free Full Text]
  33. Thomas, M. L., E. J. Brown. 1999. Positive and negative regulation of Src-family membrane kinases by CD45. Immunol. Today 20: 406-411. [Medline]
  34. Filipp, D., J. Zhang, B. L. Leung, A. Shaw, S. D. Levin, A. Veillette, M. Julius. 2003. Regulation of Fyn through translocation of activated Lck into lipid rafts. J. Exp. Med. 197: 1221-1227. [Abstract/Free Full Text]
  35. Filipp, D., B. L. Leung, J. Zhang, A. Veillette, M. Julius. 2004. Enrichment of lck in lipid rafts regulates colocalized fyn activation and the initiation of proximal signals through TCR{alpha}{beta}. J. Immunol. 172: 4266-4274. [Abstract/Free Full Text]
  36. Brdicka, T., D. Pavlistova, A. Leo, E. Bruyns, V. Korinek, P. Angelisova, J. Scherer, A. Shevchenko, I. Hilgert, J. Cerny, et al 2000. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J. Exp. Med. 191: 1591-1604. [Abstract/Free Full Text]
  37. Kawabuchi, M., Y. Satomi, T. Takao, Y. Shimonishi, S. Nada, K. Nagai, A. Tarakhovsky, M. Okada. 2000. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 404: 999-1003. [Medline]
  38. Davidson, D., M. Bakinowski, M. L. Thomas, V. Horejsi, A. Veillette. 2003. Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol. Cell. Biol. 23: 2017-2028. [Abstract/Free Full Text]
  39. Cloutier, J. F., A. Veillette. 1996. Association of inhibitory protein tyrosine kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J. 15: 4909-4918. [Medline]
  40. Cloutier, J. F., A. Veillette. 1999. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med. 189: 111-121. [Abstract/Free Full Text]
  41. Torgersen, K. M., T. Vang, H. Abrahamsen, S. Yaqub, V. Horejsi, B. Schraven, B. Rolstad, T. Mustelin, K. Tasken. 2001. Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts. J. Biol. Chem. 276: 29313-29318. [Abstract/Free Full Text]
  42. Dykstra, M., A. Cherukuri, H. W. Sohn, S. J. Tzeng, S. K. Pierce. 2003. Location is everything: lipid rafts and immune cell signaling. Annu. Rev. Immunol. 21: 457-481. [Medline]
  43. Janes, P. W., S. C. Ley, I. Magee. 1999. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J. Cell Biol. 147: 447-461. [Abstract/Free Full Text]
  44. Lim, K. L., P. R. Kolatkar, K. P. Ng, C. H. Ng, C. J. Pallen. 1998. Interconversion of the kinetic identities of the tandem catalytic domains of receptor-like protein tyrosine phosphatase PTP{alpha} by two point mutations is synergistic and substrate-dependent. J. Biol. Chem. 273: 28986-28993. [Abstract/Free Full Text]
  45. Kosugi, A., J. Sakakura, K. Yasuda, M. Ogata, T. Hamaoka. 2001. Involvement of SHP-1 tyrosine phosphatase in TCR-mediated signaling pathways in lipid rafts. Immunity 14: 669-680. [Medline]
  46. Davidson, D., L. M. Chow, M. Fournel, A. Veillette. 1992. Differential regulation of T cell antigen responsiveness by isoforms of the src-related tyrosine protein kinase p59fyn. J. Exp. Med. 175: 1483-1492. [Abstract/Free Full Text]
  47. Hermiston, M. L., Z. Xu, A. Weiss. 2003. CD45: a critical regulator of signaling thresholds in immune cells. Annu. Rev. Immunol. 21: 107-137. [Medline]
  48. Yasuda, K., M. Nagafuku, T. Shima, M. Okada, T. Yagi, T. Yamada, Y. Minaki, A. Kato, S. Tani-Ichi, T. Hamaoka, et al 2002. Cutting edge: Fyn is essential for tyrosine phosphorylation of Csk-binding protein/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells. J. Immunol. 169: 2813-2817. [Abstract/Free Full Text]
  49. Zhang, W., R. P. Trible, L. E. Samelson. 1998. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 9: 239-246. [Medline]
  50. Edmonds, S. D., H. L. Ostergaard. 2002. Dynamic association of CD45 with detergent-insoluble microdomains in T lymphocytes. J. Immunol. 169: 5036-5042. [Abstract/Free Full Text]
  51. Giurisato, E., D. P. McIntosh, M. Tassi, A. Gamberucci, A. Benedetti. 2003. T cell receptor can be recruited to a subset of plasma membrane rafts, independently of cell signaling and attendantly to raft clustering. J. Biol. Chem. 278: 6771-6778. [Abstract/Free Full Text]
  52. Schuck, S., M. Honsho, K. Ekroos, K. Simons. 2003. Resistance of cell membranes to different detergent. Proc. Natl. Acad. Sci. USA 100: 5795-5800. [Abstract/Free Full Text]
  53. Ashwell, J. D., U. D’Oro. 1999. CD45 and Src-family kinases: and now for something completely different. Immunol. Today 20: 412-416. [Medline]
  54. Stone, J. D., L. A. Conroy, K. F. Byth, R. A. Hederer, S. Howlett, Y. Takemoto, N. Holmes, D. R. Alexander. 1997. Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-{zeta}, and Zap-70. J. Immunol. 158: 5773-5782. [Abstract]
  55. Pingel, J. T., M. L. Thomas. 1989. Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 58: 1055-1065. [Medline]
  56. Koretzky, G. A., J. Picus, M. L. Thomas, A. Weiss. 1990. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature 346: 66-68. [Medline]
  57. Koretzky, G. A., J. Picus, T. Schultz, A. Weiss. 1991. Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc. Natl. Acad. Sci. USA 88: 2037-2041. [Abstract/Free Full Text]
  58. Byth, K. F., L. A. Conroy, S. Howlett, A. J. Smith, J. May, D. R. Alexander, N. Holmes. 1996. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J. Exp. Med. 183: 1707-1718. [Abstract/Free Full Text]
  59. Mee, P. J., M. Turner, M. A. Basson, P. S. Costello, R. Zamoyska, V. L. Tybulewicz. 1999. Greatly reduced efficiency of both positive and negative selection of thymocytes in CD45 tyrosine phosphatase-deficient mice. Eur. J. Immunol. 29: 2923-2933. [Medline]
  60. Kishihara, K., J. Penninger, V. A. Wallace, T. M. Kundig, K. Kawai, A. Wakeham, E. Timms, K. Pfeffer, P. S. Ohashi, M. L. Thomas, et al 1993. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 74: 143-156. [Medline]
  61. Ng, D. H., M. D. Jabali, A. Maiti, P. Borodchak, K. W. Harder, T. Brocker, B. Malissen, F. R. Jirik, P. Johnson. 1997. CD45 and RPTP{alpha} display different protein tyrosine phosphatase activities in T lymphocytes. Biochem. J. 327: 867-876. [Medline]
  62. Dornan, S., Z. Sebestyen, J. Gamble, P. Nagy, A. Bodnar, L. Alldridge, S. Doe, N. Holmes, L. K. Goff, P. Beverley, et al 2002. Differential association of CD45 isoforms with CD4 and CD8 regulates the actions of specific pools of p56lck tyrosine kinase in T cell antigen receptor signal transduction. J. Biol. Chem. 277: 1912-1918. [Abstract/Free Full Text]
  63. Zeng, L., L. D’Alessandri, M. B. Kalousek, L. Vaughan, C. J. Pallen. 1999. Protein tyrosine phosphatase {alpha} (PTP{alpha}) and contactin form a novel neuronal receptor complex linked to the intracellular tyrosine kinase fyn. J. Cell Biol. 147: 707-714. [Abstract/Free Full Text]
  64. Friedrichson, T., T. V. Kurzchalia. 1998. Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature 394: 802-805. [Medline]
  65. Varma, R., S. Mayor. 1998. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394: 798-801. [Medline]
  66. Quill, H., M. P. Riley, E. A. Cho, J. E. Casnellie, J. C. Reed, T. Torigoe. 1992. Anergic Th1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn. J. Immunol. 149: 2887-2893. [Abstract]
  67. Gajewski, T. F., D. Qian, P. Fields, F. W. Fitch. 1994. Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc. Natl. Acad. Sci. USA 91: 38-42. [Abstract/Free Full Text]
  68. Utting, O., S. J. Teh, H. S. Teh. 2000. A population of in vivo anergized T cells with a lower activation threshold for the induction of CD25 exhibit differential requirements in mobilization of intracellular calcium and mitogen-activated protein kinase activation. J. Immunol. 164: 2881-2889. [Abstract/Free Full Text]
  69. Welke, J., N. Zavazava. 2002. p59fyn is upregulated in anergic CD8+ T cells. Hum. Immunol. 63: 834-843. [Medline]
  70. Griffiths, E. K., C. Krawczyk, Y. Y. Kong, M. Raab, S. J. Hyduk, D. Bouchard, V. S. Chan, I. Kozieradzki, A. J. Oliveira-Dos-Santos, A. Wakeham, et al 2001. Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap. Science 293: 2260-2263. [Abstract/Free Full Text]
  71. Peterson, E. J., M. L. Woods, S. A. Dmowski, G. Derimanov, M. S. Jordan, J. N. Wu, P. S. Myung, Q. H. Liu, J. T. Pribila, B. D. Freedman, et al 2001. Coupling of the TCR to integrin activation by Slap-130/Fyb. Science 293: 2263-2265. [Abstract/Free Full Text]
  72. Luo, H., G. Yu, J. Tremblay, J. Wu. 2004. EphB6-null mutation results in compromised T cell function. J. Clin. Invest. 114: 1762-1773. [Medline]
  73. Van Seventer, G. A., Y. Shimizu, K. J. Horgan, S. Shaw. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144: 4579-4586. [Abstract]
  74. Zell, T., W. J. Kivens, S. A. Kellermann, Y. Shimizu. 1999. Regulation of integrin function by T cell activation: points of convergence and divergence. Immunol. Res. 20: 127-145. [Medline]
  75. Yarovinsky, T. O., M. M. Monick, G. W. Hunninghake. 2003. Integrin receptors are crucial for the restimulation of activated T lymphocytes. Am. J. Respir. Cell Mol. Biol. 28: 607-615. [Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
N. Vacaresse, B. Moller, E. M. Danielsen, M. Okada, and J. Sap
Activation of c-Src and Fyn Kinases by Protein-tyrosine Phosphatase RPTP{alpha} Is Substrate-specific and Compatible with Lipid Raft Localization
J. Biol. Chem., December 19, 2008; 283(51): 35815 - 35824.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. A. Samayawardhena and C. J. Pallen
Protein-tyrosine Phosphatase {alpha} Regulates Stem Cell Factor-dependent c-Kit Activation and Migration of Mast Cells
J. Biol. Chem., October 24, 2008; 283(43): 29175 - 29185.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Cao, K. Yu, C. Banh, V. Nguyen, A. Ritz, B. J. Raphael, Y. Kawakami, T. Kawakami, and A. R. Salomon
Quantitative Time-Resolved Phosphoproteomic Analysis of Mast Cell Signaling
J. Immunol., November 1, 2007; 179(9): 5864 - 5876.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
E. Sandilands, V. G. Brunton, and M. C. Frame
The membrane targeting and spatial activation of Src, Yes and Fyn is influenced by palmitoylation and distinct RhoB/RhoD endosome requirements
J. Cell Sci., August 1, 2007; 120(15): 2555 - 2564.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Maksumova, Y. Wang, N. K. Y. Wong, H. T. Le, C. J. Pallen, and P. Johnson
Differential Function of PTP{alpha} and PTP{alpha} Y789F in T Cells and Regulation of PTP{alpha} Phosphorylation at Tyr-789 by CD45
J. Biol. Chem., July 20, 2007; 282(29): 20925 - 20932.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Smida, A. Posevitz-Fejfar, V. Horejsi, B. Schraven, and J. A. Lindquist
A novel negative regulatory function of the phosphoprotein associated with glycosphingolipid-enriched microdomains: blocking Ras activation
Blood, July 15, 2007; 110(2): 596 - 625.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maksumova, L.
Right arrow Articles by Pallen, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maksumova, L.
Right arrow Articles by Pallen, C. J.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS